Navigation Links
Manipulating Key Protein May Prevent Eczema
Date:12/17/2008

Study might lead to new treatments for itchy skin condition

WEDNESDAY, Dec. 17 (HealthDay News) -- The discovery of a protein that seems to contribute to the development of eczema may one day lead to preventive treatments for the itchy and often painful skin condition -- at least if new research with mice applies to people.

For the study, researchers worked with two groups of mice -- one that had a receptor for the protein called IL-21, and one that did not. Both groups were shaved and their skin irritated using sticky tape to mimic the effect that scratching or damaging the skin would have in humans. In humans prone to eczema, this type of irritation would likely lead to an aggravated immune response and a worsening of eczema.

Researchers found that the presence of IL-21 was essential to the inflammation characteristic of eczema.

"We used mice that were genetically deficient in the receptor for IL-21 and these mice did not develop the disease, so the receptor is one of the critical factors for the development of eczema," said study author Dr. Raif Geha, chief of the children's division of allergy/immunology at Children's Hospital Boston and Harvard Medical School.

Geha and his colleagues found that even mice with IL-21 receptors could be spared from developing eczema by pumping them with a decoy receptor to fool their immune system and keep it from attacking the inflamed area. The finding offers further evidence that IL-21 is important in the formation of the disease and could point the way to future treatments, he said.

But, Geha added, much more research with animals is needed before the approach could be tried with people.

"One limitation is that while the mice didn't develop any side effects, we don't know if the same strategy would have side effects in humans," he said. "The other limitation is that we don't know if the agent will work after the eczema sets in."

Geha said future treatments might target individuals prone to eczema before they begin to show symptoms, but, again, much research remains to be done.

The study findings were published in the December issue of the Journal of Clinical Investigation.

More information

To learn more about eczema, visit the U.S. National Library of Medicine.



SOURCES: Raif Geha, M.D., the James Gamble Professor of Pediatrics, Harvard Medical School, and chief, children's division of allergy/immunology, Children's Hospital, Boston; December 2008 Journal of Clinical Investigation


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Manipulating the immune system like a parasite
2. Draining away brains toxic protein to stop Alzheimers
3. Penn study finds pro-death proteins required to regulate healthy immune function
4. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
5. Emory researchers identify signaling protein for multiple myeloma
6. Human C-reactive protein regulates myeloma tumor cell growth and survival
7. Lowering Blood Protein Wont Help Kidney Patients
8. Blood protein detects lung cancer, even at earliest stage
9. Natural Protein Could Help Spot, Treat Liver Cancer
10. Heat shock proteins are co-opted for cancer
11. How adhesive protein causes malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: